Address & Contact Info Changes:
Please promptly notify the Administrator of any changes to your contact information as we use what’s on file to communicate with you. When providing changes, please provide your full name, your File ID (if applicable), as well as confirm the old contact information and the change requested.
Applicants to the CTSSP:
Process change as a result of a new Judgment released on August 9th, 2022. Please click here for more information.
A settlement between the Federal Government of Canada (“Canada”) and Bruce Wenham of Toronto, Ontario (the “Representative Applicant”) has been approved by the Federal Court and is now final. Please click here for more information.
CTSSP Application Deadline:
Step 1 – Preliminary Screening Applications are now available for any living individual who believes that they are a Thalidomide Survivor, including those previously denied under the 1991 EAP or the 2015 TSCP. Click here to download the form or call 1-877-507-7706 (TTY: 1-877-627-7027) to have one sent to you. The CTSSP Application deadline is postmarked by June 3, 2024 to the Administrator.
Reassessment:
Confirmed Survivors who are currently at a level 1 or a level 2, may request reassessment of their health status once per fiscal year or more frequently if there is an urgent need. Click here to download the application.
EMAF:
There is no limit as to how many applications you may submit as the Administrator has removed the yearly submission deadline date to make the process easier for you. Please submit a new application whenever you wish; however, the Administrator requests that you accumulate $500 worth of expenses before sending in your application unless it creates a financial hardship for you. Click here to download the application.
You may also call the Administrator at 1-877-507-7706 (TTY: 1-877-627-7027) or by email to info@tsspcanada.ca to have any of the forms sent to you by mail or email.
Please refresh your Internet browser pages to see the latest website updates.
The Canadian Thalidomide Survivors Support Program (“CTSSP”) is a financial support package for Canadian Thalidomide Survivors, announced by the Minister of Health on January 9, 2019.
Thalidomide Survivors who were already confirmed under the Government of Canada’s 1991 Extraordinary Assistance Plan (”EAP”) for Thalidomide Victims and/or the former Thalidomide Survivors Contribution Program (”TSCP”) were transferred automatically to the new Canadian Thalidomide Survivors Support Program (“CTSSP”) without the need to re-apply.
Anyone who believes that they are a Thalidomide survivor, including those previously refused by the 1991 EAP or the 2015 TSCP, may apply for assessment under the new CTSSP program.
The CTSSP is intended to contribute to meeting the needs of Thalidomide Survivors for the remainder of their lives so that they may age with dignity.
- A five-year time frame to apply to the CTSSP, beginning June 3, 2019 and ending June 3, 2024, for those individuals who believe they are a Thalidomide Survivor. Individuals denied under the Government of Canada’s 1991 Extraordinary Assistance Plan (“EAP”) or the 2015 Thalidomide Survivors Contribution Program (“TSCP”) are also eligible to apply
- A probability-based medical assessment process to determine if individuals are Thalidomide Survivors employing techniques utilized in other international Thalidomide Survivor programs;
- An increased initial ex gratia lump sum, tax-free payment of $250,000 for Survivors confirmed under the new CTSSP. Survivors already recognized under the former TSCP received a top up payment of $125,000 to equalize the ex gratia amount payable to all Survivors under the two programs;
- Ongoing annual tax-free payments to Thalidomide Survivors indexed at 2% per year for life based on each individual’s assessed level of disability;
- Access to an annual Extraordinary Medical Assistance Fund (“EMAF”) to help cover the costs of extraordinary health support costs of Thalidomide Survivors with needs such as specialized surgeries and home or vehicle adaptations that are not otherwise provided in provincial/territorial healthcare plans;
- An increase to the EMAF to $1 M per year, indexed at 2% per year, to account for an anticipated greater number of confirmed survivors.
Any individual who believes that they are a Thalidomide Survivor, including those previously denied under the 1991 EAP or the 2015 TSCP, can apply for assessment under the CTSSP. Click here for more information.
Thalidomide Survivors who were already confirmed under the 1991 EAP and/or the former TSCP will automatically be transferred to the new Canadian Thalidomide Survivors Support Program (“CTSSP”) without the need to re-apply.
Health Canada will contact existing Confirmed Thalidomide Survivors directly to arrange payment of the CTSSP ex gratia $125,000 top up payment.
Annual ongoing support payments will continue uninterrupted for the Confirmed Thalidomide Survivor’s lifetime.
- Ongoing Tax Free Support Payments
- Extraordinary Medical Assistance Fund
- Health Status Reassessments